Transcripta Bio Named to the TIME100 Most Influential Companies of 2024
Transcripta Bio , a platform drug development biotechnology company that is revolutionizing discovering and developing medicines at unprecedented speed, scale, and capital efficiency, has been included in the fourth-annual TIME100 Most Influential Companies list .
- Transcripta Bio , a platform drug development biotechnology company that is revolutionizing discovering and developing medicines at unprecedented speed, scale, and capital efficiency, has been included in the fourth-annual TIME100 Most Influential Companies list .
- The prestigious list spotlights companies around the world that are making an extraordinary impact and recognizes Transcripta Bio’s significant achievements in speeding drug discovery.
- “We are honored to be included in the TIME100 Most Influential Companies list and recognized for our groundbreaking advancements in drug discovery,” said Chris Moxham, co-founder, CEO, and Chief Scientific Officer, Transcripta Bio.
- By building cutting-edge technology and forging strategic partnerships, Transcripta Bio is dramatically accelerating the global drug discovery process.